Tango Therapeutics Inc. Revenue 2020–2025
Tango Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Tango Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Tango Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 62.4 M, a 28.14% increase year-over-year.
- Tango Therapeutics Inc. annual revenue for 2025 was 62.4 M, a 48.29% increase from 2024.
- Tango Therapeutics Inc. annual revenue for 2024 was 42.1 M, a 15.17% increase from 2023.
- Tango Therapeutics Inc. annual revenue for 2023 was 36.5 M, a 46.93% increase from 2022.
- Tango Therapeutics Inc. annual revenue for 2022 was 24.9 M.
Tango Therapeutics Inc. (TNGX) — Frequently Asked Questions
Tango Therapeutics Inc. (TNGX) is a publicly traded US company. It has a market capitalization of $3.28B. In fiscal 2025 it reported revenue of $62M and net income of -$102M. Explore TNGX's stock price, financial statements, earnings history, margins and key ratios below.
What is Tango Therapeutics Inc.'s market cap?
Tango Therapeutics Inc. (TNGX) has a market capitalization of $3.28B.
What is the TNGX stock price?
TNGX trades at $28.26 (-1.46% on the day).
How much revenue does Tango Therapeutics Inc. make?
Tango Therapeutics Inc. reported revenue of $62M in fiscal 2025.
Is TNGX profitable?
In fiscal 2025, Tango Therapeutics Inc. reported net income of -$102M.